Cargando...
Aromatase Inhibitor, Tamoxifen and Endometrial Cancer in Breast Cancer Survivors
BACKGROUND: Both endometrial cancer and postmenopausal breast cancer risk are increased by obesity and higher endogenous estrogen levels. While aromatase inhibitors reduce breast cancer incidence, their influence on endometrial cancer is uncertain. METHODS: We addressed this issue in a cohort of 17,...
Guardado en:
| Publicado en: | Cancer |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4565775/ https://ncbi.nlm.nih.gov/pubmed/25757699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29332 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|